“…The heterogeneity test showed significant differences among the subgroups (80.5% and 73.4%, respectively). However, we did not find significant differences in studies 8,9,11,13 measuring postimplantation QRSd after a certain follow-up period compared with studies 7,10,12,14e18 measuring QRSd immediately after CRT device implantation (À19.37 The American Journal of Cardiology (www.ajconline.org) vs À19.31 ms) without any heterogeneity among the individual studies (I 2 ¼ 0%). In addition, the sensitivity analysis showed that heterogeneity across studies was reduced when we excluded the study by Lecoq et al 9 where the inclusion criteria for QRSd was at least 150 ms (I 2 ¼ 33%) or the study by Zhang et al 18 that enrolled only patients with dilated cardiomyopathy (I 2 ¼ 31%), without changing the overall effect.…”